Literature DB >> 15100646

Flutamide as a preoperative treatment in juvenile angiofibroma (JA) with intracranial invasion: report of 7 cases.

Alberto Labra1, Rogelio Chavolla-Magaña, Adriana Lopez-Ugalde, Jorge Alanis-Calderon, Angel Huerta-Delgado.   

Abstract

OBJECTIVE: To determine the efficacy of flutamide as a tumor reduction factor in patients who have juvenile angiofibroma (JA) with intracranial invasion.
DESIGN: A longitudinal, prospective, experimental, self-controlled pilot study.
MATERIAL AND METHODS: Seven consecutive patients with JA were enrolled in the study. CT scan with measurements of the tumor was performed before and after the treatment with flutamide, and the results were compared.
RESULTS: The biggest reduction in tumor size was 11.1%. All patients underwent surgical resection, and the bleeding was similar to patients without flutamide. No statistically significant difference was found between the measurements before and after the flutamide administration.
CONCLUSIONS: Despite the fact that there is a report of the efficacy of flutamide in the literature, we did not find advantages in using it in patients with JA. However, and due to the very small number of patients enrolled, we think that more studies are required.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100646     DOI: 10.1016/j.otohns.2004.01.007

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  6 in total

1.  Nasopharyngeal Angiofibroma-changing Trends in the Management.

Authors:  Naresh K Panda; Gaurav Gupta; Suresh Sharma; Ashok Gupta
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-11-30

2.  Immunohistochemical analysis of growth mechanisms in juvenile nasopharyngeal angiofibroma.

Authors:  Robert Schuon; Jürgen Brieger; Ulf R Heinrich; Yeduha Roth; Witold Szyfter; Wolf J Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-12-20       Impact factor: 2.503

3.  Nasopharyngeal Angiofibroma: A Clinical, Histopathological and Immunohistochemical Study of 42 Cases with Emphasis on Stromal Features.

Authors:  Celeste Sánchez-Romero; Roman Carlos; Juan Pablo Díaz Molina; Lester D R Thompson; Oslei Paes de Almeida; Alicia Rumayor Piña
Journal:  Head Neck Pathol       Date:  2017-05-15

4.  Nasopharyngeal angiofibroma in a 32-year-old man.

Authors:  Patrick O McGarey; Abel P David; Spencer C Payne
Journal:  BMJ Case Rep       Date:  2018-02-08

5.  Endonasal endoscopic management of juvenile nasopharyngeal angiofibroma without angiographic embolization.

Authors:  Asser A El Sharkawy
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-28       Impact factor: 2.503

6.  Juvenile angiofibroma: evolution of management.

Authors:  Piero Nicolai; Alberto Schreiber; Andrea Bolzoni Villaret
Journal:  Int J Pediatr       Date:  2011-11-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.